Literature DB >> 1790637

The actual survival rate in systemic lupus erythematosus: study of a 1976 cohort.

M Breban1, O Meyer, P Bourgeois, E Palazzo, M F Kahn.   

Abstract

The purpose of this study was to establish the actual survival rate of a cohort of 51 patients with systemic lupus erythematosus (SLE) all of whom were followed during 12 years from 1976 to 1988 and to evaluate the prognostic significance of the severe complications of the disease. Forty-eight were females. The mean age was 28.5 at onset, 36.2 at diagnosis and 42 at entry; 80% had four or more 1982 ARA criteria at diagnosis and 96% in 1988. Survival rates were: 96% at two years, 86.3% at five years and 74.5% at twelve years. The main cause of death was infection (62%); SLE was directly responsible in only one case. Manifestations considered as severe occurred in almost two-thirds of the cases without any concordance in the time sufficient to recognize different severe forms of the disease.

Entities:  

Mesh:

Year:  1991        PMID: 1790637     DOI: 10.1007/bf02208691

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  32 in total

1.  CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

Authors:  E L DUBOIS; D L TUFFANELLI
Journal:  JAMA       Date:  1964-10-12       Impact factor: 56.272

2.  Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors.

Authors:  S Studenski; N B Allen; D S Caldwell; J R Rice; R P Polisson
Journal:  Arthritis Rheum       Date:  1987-12

Review 3.  The natural history of systemic lupus erythematosus by prospective analysis.

Authors:  D Estes; C L Christian
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

4.  The bimodal mortality pattern of systemic lupus erythematosus.

Authors:  M B Urowitz; A A Bookman; B E Koehler; D A Gordon; H A Smythe; M A Ogryzlo
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

5.  Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.

Authors:  M C Hochberg; R E Boyd; J M Ahearn; F C Arnett; W B Bias; T T Provost; M B Stevens
Journal:  Medicine (Baltimore)       Date:  1985-09       Impact factor: 1.889

6.  Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus.

Authors:  J Baum; M Ziff
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

7.  Systemic lupus erythematosus. Follow-up study of 148 patients. II: Predictive factors of importance for course and outcome.

Authors:  P Halberg; B Alsbjørn; J T Balslev; I Lorenzen; J Gerstoft; S Ullman; A Wiik
Journal:  Clin Rheumatol       Date:  1987-03       Impact factor: 2.980

8.  Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria.

Authors:  O Nived; G Sturfelt; F Wollheim
Journal:  Br J Rheumatol       Date:  1985-05

9.  Systemic lupus erythematosus--survival patterns. Experience with 609 patients.

Authors:  D J Wallace; T Podell; J Weiner; J R Klinenberg; S Forouzesh; E L Dubois
Journal:  JAMA       Date:  1981-03-06       Impact factor: 56.272

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  2 in total

Review 1.  Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review.

Authors:  Matthew E Falagas; Katerina G Manta; Gregoria I Betsi; Georgios Pappas
Journal:  Clin Rheumatol       Date:  2006-12-21       Impact factor: 2.980

2.  Long-term management after splenectomy. Consider prophylaxis in systematic lupus erythematosus.

Authors:  K A Davies; H L Beynon; M J Walport
Journal:  BMJ       Date:  1994-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.